Physician profile
Sonyta So
NPI 1386983898
$3,769.59
in general payments reported to CMS, 2019-2025
37 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,749 · 2022: $1,420 · 2023: $414 · 2024: $80.54 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $530.36 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $445.13 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $332.34 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.85 | 2021-2022 | |
| Pfizer INC. | $268.38 | 2021-2023 | |
| Abbott Laboratories | $228.74 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $186.23 | 2021-2023 | Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $163.49 | 2021-2022 | |
| Lilly USA, LLC | $141.18 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $109.15 | 2021-2023 | Farxiga |
| Genentech USA, INC. | $106.94 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $104.26 | 2021-2022 | |
| Glaxosmithkline, LLC. | $81.52 | 2021-2025 | Arexvy, Shingrix, Bexsero |
| Amarin Pharma, INC. | $66.04 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $59.82 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $57.44 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $52.35 | 2021 | |
| Corium, LLC | $50.47 | 2022 | |
| Optinose US, INC. | $50.32 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.03 | 2021-2023 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $40.82 | 2021 | |
| Stryker Corporation | $40.71 | 2023 | 7 X 23mm Citrelock Implant |
| Vbi Vaccine (Delaware) INC. | $37.42 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $36.33 | 2022 | |
| Horizon Therapeutics Plc | $33.14 | 2022 | |
| Merck Sharp & Dohme LLC | $31.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.10 | 2022 | |
| Dexcom, INC. | $21.24 | 2023 | Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $19.35 | 2021 | |
| Becton, Dickinson and Company | $18.58 | 2021 | |
| Aytu Biopharma, INC. | $17.84 | 2021 | |
| Astellas Pharma US INC | $17.67 | 2023 | Veozah |
| Exact Sciences Corporation | $16.69 | 2023 | Cologuard Collection Kit |
| Biocryst US Sales Co., LLC | $16.38 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.29 | 2022 | |
| Eisai INC. | $14.89 | 2021 | |
| Sanofi Pasteur INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonyta So listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.